With a 5.98% market share, India is the fourth-largest pharmaceutical supplier to the U.S., behind Ireland, Switzerland, and ...

The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the ...

A day earlier, Trump signed an executive order imposing an additional 25% on India, taking the total duty to 50%, among the ...